Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-emulgel fluconazole versus oral fluconazole for cutaneous dermatophytosis
IRCT20190326043113N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of fluconazole in dermatophytosis (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Irritation, Itching and 2 more. Started Sep 2018; status: completed.
02
Drugs
fluconazole
03
Conditions
dermatophytosis
Beyond the preview
Go deeper on IRCT20190326043113N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190326043113N1.